What the UK’s largest active medical cannabis patient survey revealed about gastroenterological conditions
96.1% of UK gastroenterological patients surveyed in Releaf’s 2025 medical cannabis survey said their prescribed medical cannabis treatment was effective at managing their symptoms, 97.4% reported improvements in their overall quality of life, and 98.7% said they would recommend medical cannabis treatment to someone with a similar qualifying condition.
8 min readUK medical cannabis patient survey 2025: Seven years since legalisation
To mark the seventh anniversary of medical cannabis legalisation in the UK, Releaf conducted a nationwide study involving 1,669 patients - the largest survey of prescribed medical cannabis patients ever undertaken in the country.
6 min readStatistic series: Google search trends for medical cannabis in the UK
In today’s modern world, when people want to know something, often the first thing they do is turn to Google, and so, the internet can act as a mirror and reflect what society is interested in.
8 min read
Consultations now £29.99 (was £99.99) → Am I eligible?
Questions? Search our guides & videos
Risk free! See our Money-back eligibility guarantee
Over 260,000 people in the Releaf community!
Are you eligible? Find out in 2 minutes!
Order by 2pm for same-day dispatch!
"Since starting my treatment plan with Releaf, I’m genuinely shocked at how well it has worked."Chloe Durrington, Releaf patient